Temporarily amended procedures
Due to the coronavirus outbreak, the Research Review Department has amended its procedures. Please check this page regularly for updates.

Amended procedures uitklapper, klik om te openen

Availability of the secretariat

In connection with the measures taken to prevent the novel coronavirus from spreading, employees of the secretariat are mainly working from home at the moment. This means that there is currently no ‘open office hour’. As of 31 August 2020 you can contact us again by telephone Monday to Thursday from 1 to 4 p.m.  You can also contact the secretariatvia e-mail. If you wish to consult with us, then please describe your question in your e-mail, and provide the telephone number on which we can contact you. We will answer your question as soon as possible, either by phone or via e-mail.

Study submission

Research files have to be submitted entirely digitally for the time being. Please refer to the page How to submit for instructions on how to submit your file digitally.


The requirement to provide a cover letter with a wet signature for primary submission and substantial amendments has been suspended. Instead, a digital or scanned signature of the applicant will suffice. This also applies to appeals and objections.

Fast-track procedure for review of COVID-19 research files

If you wish to submit a file for COVID-19 research subject and if in your opinion fast-track review is necessary, please inform us of this beforehand (if possible several days in advance) and substantiate the need for a fast-track review procedure. Please also indicate what kind of study it concerns (e.g. research with a medicinal product or another type of research, which phase, interventional/observational, etc.). The subject line should read ‘urgent request / file concerning COVID-19’. The committee will then assess whether fast-track planning is necessary and feasible. For fast-track review by the competent authority, you can send an e-mail to or info-bi@cbg-meb.nlstating ‘FAST TRACK COVID-19’.

Submitters of non-registered COVID vaccine studies and multinational studies using drugs for the treatment of COVID who submitted it via CTIS, should contact the CCMO at to discuss options for accelerated review (fast-track procedure).

Notification of temporary suspension of research

Please use the Template (Dutch only) for notification of study suspension for this.  On the CCMO website you can read when this is applicable. For UMC Utrecht investigators, amended rules apply; you will find more information about this on Connect

European guideline (EMA) uitklapper, klik om te openen

European guideline (EMA) for the performance of clinical research during the coronavirus crisis

For UMCU investigators uitklapper, klik om te openen

Signature of the Research Manager

Please ask the Quality Coordinator what the options are.

Information on Connect

Update 01-24-2022

Participating institutions: UMC Utrecht, Prinses Máxima Centrum for pediatric oncology and Antoni van Leeuwenhoek

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

NedMec maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid